Altogen Biosystems is a global producer and custom research
organization for the pharmaceutical industry. Biological products and other
goods include ELISA testing, optimization of preclinical research, stable
transfection of cells, IND applications and more. Dedicated to helping
researchers with state-of-the-art and efficient services, Altogen Biosystems
strives to further modern clinical techniques. Visit the Altogen Biosystems
website for lung
xenograft models and related tools for preclinical drug testing.
The NCI-H358 cell line was first established in 1981 from removed bronchiole tissue of a patient suffering from bronchioalveolar carcinoma (lung cancer). The tissue was removed from the patient prior to any administered chemotherapy treatments. The NCI-H358 cell line has a doubling time of about 38 hours, it has detectable Clara cells and is an exceptional transfection host. This cell line is also a great candidate for in vitro research studies, such as those at Altogen Biosystems . T he in vitro research models are helpful to solving lung cancer and useful as transfection hosts. Transfection Reagent for NCI-H358 Cells (Bronchioalveolar Cells, CRL-5807)
Comments
Post a Comment